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A B S T R A C T
Health care forms a large economic sector in all countries, and procurement of medicines and other essential
commodities necessarily creates economic linkages between a country's health sector and local and international
industrial development. These procurement processes may be positive or negative in their eﬀects on populations'
access to appropriate treatment and on local industrial development, yet procurement in low and middle income
countries (LMICs) remains under-studied: generally analysed, when addressed at all, as a public sector technical
and organisational challenge rather than a social and economic element of health system governance shaping its
links to the wider economy. This article uses ﬁeldwork in Tanzania and Kenya in 2012–15 to analyse pro-
curement of essential medicines and supplies as a governance process for the health system and its industrial
links, drawing on aspects of global value chain theory. We describe procurement work processes as experienced
by front line staﬀ in public, faith-based and private sectors, linking these experiences to wholesale funding
sources and purchasing practices, and examining their implications for medicines access and for local industrial
development within these East African countries. We show that in a context of poor access to reliable medicines,
extensive reliance on private medicines purchase, and increasing globalisation of procurement systems, domestic
linkages between health and industrial sectors have been weakened, especially in Tanzania. We argue in con-
sequence for a more developmental perspective on health sector procurement design, including closer policy
attention to strengthening vertical and horizontal relational working within local health-industry value chains,
in the interests of both wider access to treatment and improved industrial development in Africa.
1. Introduction
Despite a huge increase in development aid for health and a major
improvement in access to treatment for HIV/AIDS and TB, access to
essential medicines remains a crisis in Sub-Saharan Africa (WHO,
2011). Regular stock-outs in public sector facilities, and reliance on out-
of-pocket purchase of medicines, continue to exclude low income po-
pulations from reliable access to essential medicines (Bigdeli et al.,
2014; WHO, 2011; Ewen et al., 2017).
Donors' large scale international procurement of medicines aims to
reduce prices and assure quality through pre-qualiﬁcation of suppliers,
international tendering, and pooled procurement processes (Global
Fund, 2012; P4i initiative http://www.theglobalfund.org/en/p4i/). An
acknowledged side-eﬀect has been the by-passing of local procurement
bodies or their reduction to logistics contractors, with, for some policy
actors, the explicit objective of bypassing procurement corruption at
national level (Huﬀ-Rousselle, 2012).
There is however a long-standing theme in the literature that better
local procurement processes are needed to improve access to medicines
(Wang’Ombe and Mwabu, 1987; Waako et al., 2009; Wiedenmayer
et al., 2015). International programmes including USAID/JSI DELIVER
(http://deliver.jsi.com/dhome/), SIAPS (http://siapsprogram.org/),
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and People that Deliver (http://www.peoplethatdeliver.org/) focus
particularly on supporting local skills improvement in procurement.
Using evidence from primary research on supply chains and industrial
suppliers in Tanzania and Kenya, we argue here for an approach to
procurement analysis and policy, employing aspects of global value
chain (GVC) theory, that can that can identify and respond to the em-
beddedness of procurement processes in the governance of local health
systems and their links to the wider local economy. We aim to con-
tribute to research literature on health system strengthening including
potential beneﬁts in Africa of strengthening local industrial linkages
(Sidibé et al., 2014; Massard da Fonseca, 2017).
Throughout this article, “procurement” is deﬁned in a broad sense,
to encompass the whole set of processes for ordering and purchasing at
facility and shop level, for wholesale purchasing, and for distribution of
manufactured commodities to public, faith-based and private health
facilities, and to shops. This deﬁnition is in line with the usage of our
interviewees.
2. Methods
This article presents evidence from a study of procurement of
medicines and supplies in Tanzania and Kenya, and of related manu-
facturing-health sector linkages (see Acknowledgements). In a ﬁrst
stage (2012–13), a convergent mixed methods design (Ozawa and
Pongpirul, 2013) used qualitative in-depth interviews to explore pro-
curement processes and experience, in 42 health facilities, pharmacies
and drug shops in Tanzania, and 55 in Kenya, alongside quantitative
data capture of availability and source of a set of tracer essential
medicines, supplies and equipment. The tracer commodities (listed in
web-based supplementary material), similar but not identical in each
country, were selected following advice from national clinical and
regulatory experts, and encompass a range of essential generic medi-
cines and basic medical equipment and supplies, laboratory supplies
and other basics such as bed sheets and cleaning materials.
Table 1 shows interview distribution by sector. (The Accredited
Drug Dispensing Outlets, ADDOs, are Tanzania's regulated drug shops).
All tables and quotations are from authors' ﬁeldwork unless otherwise
indicated.
Facilities were purposively selected from public, faith-based/NGO
and private sectors, spread geographically across four districts
(Tanzania) or counties (Kenya). Locations were chosen to represent a
wide range of geographical area, incomes, infrastructure and health
outcomes. In Kenya they included two contrasting areas of Nairobi (one
high-income, to capture supply chains to private sector facilities), and
two rural counties, one on the coast and one in the Rift Valley bordering
Tanzania. In Tanzania they included two urban districts, one in Dar es
Salaam and one in Arusha region, plus two rural districts, one on the
coast, and one towards the Kenyan border to capture cross-border
supply chains. In all, 79 semi-structured interviews were conducted in
Tanzania and 81 in Kenya, covering sources and procurement
processes, supply gaps and opinions on local versus imported supplies,
for medicines, medical supplies and equipment, laboratory supplies and
basics such as bed nets, sheets and cleaning materials. In Kenya these
interviews were carried out before the decentralisation of public sector
procurement to counties (KEMSA nd).
In a second stage in 2013–14, 15 interviews were conducted in
Tanzania and 14 in Kenya with wholesalers, procurement agents, reg-
ulators, government oﬃcials and manufacturing associations. In
Tanzania 11, and in Kenya 12, locally based manufacturers of medi-
cines, medical and other supplies, and of inputs such as packaging, were
also interviewed, on business history and strategy, production organi-
sation and technology, domestic and export market access, experience
of health sector procurement, and business challenges and constraints.
Quantitative data were analysed using Stata. Qualitative interviews,
both transcribed recordings and verbatim notes, were entered into
NVivo for coding and exploration of concepts and arguments. Data from
diﬀerent sources were triangulated, and interpretations discussed by
the authors.
Ethical clearance was obtained from the Open University Human
Research Ethics Committee in the UK, the Kenyatta National Hospital
Ethical Review Board in Kenya, and the National Institute for Medical
Research Ethics Review Committee in Tanzania. All participants had
consented to the research, having been assured that participation was
voluntary and that their anonymity would be preserved in published
research ﬁndings.
3. Analysing procurement: a value chain governance framework
Current frameworks of analysis of health care procurement in Sub-
Saharan Africa (SSA) are strongly inﬂuenced by linear supply-chain
models of ‘delivery’ of medicines and other supplies from manufacturer
to end-user. Yadav (2015) and Yadav et al. (2011) frame supply chains
as technical logistical processes whereby products ﬂow from manu-
facturers (the ‘international’ level) via warehousing, storage and
transport, to clinics, health workers and drug shops (Yadav et al., 2011:
4). Reverse ﬂows of information from eﬀective ‘quantiﬁcation’ at local
level, and appropriate ﬁnancing, are required for eﬃcient supply and
delivery. While problems arising from lack of competitive pressure are
identiﬁed (Yadav, 2015), recommendations emphasise consolidation
and simpliﬁcation of linear supply chains (see also Huﬀ-Rousselle,
2012).
This supply chain management focus on logistics and quantiﬁcation
is a strength. However, ‘mapping’ of SSA supply chains has demon-
strated their complexity. “Spaghetti”-like patterns of overlapping and
multiplying supply chains have been largely driven by donors' in-
dependent procurement for vertical programmes in public and NGO
sectors (Yadav et al., 2011:6, MoHSW, 2008: 23 http://www.who.int/
medicines/areas/coordination/tanzania_mapping_supply.pdf; KEMSA
Task Force, 2008: 28 http://pdf.usaid.gov/pdf_docs/Pnadn474.pdf).
This complexity operates alongside (poorly documented) private sector
importing, wholesaling and retailing of at least half of medicines con-
sumed in Tanzania and Kenya (MSD 2013; MoMS & MPHS 2010).
While ‘deliver’ frameworks focus on logistics, health system-based
frameworks tend to overlook procurement. Analysis of medicines in
health systems has so far paid little attention to procurement processes
(e.g. Bigdeli et al., 2014). People-centred health systems analyses si-
milarly tend to omit procurement activity (e.g. Abimola et al., 2014)
despite recognising the necessarily polycentric nature of health care
governance.
We analyse procurement in this article as a governance process for
health systems and their industrial linkages, drawing on aspects of GVC
theory. Sourcing of medicines and health sector supplies for East Africa
is largely international, despite a long-standing local pharmaceutical
industry (Banda et al., 2016). GVC analysis directs attention to links
between demand, purchasing and production networks, and inter-
connections between power relations, market structures, labour
Table 1
Facilities and shops in which interviews conducted, number by sector and country.
Type of facility/shop Tanzania Kenya
Public FBO/
NGO
Private Public FBO/
NGO
Private
Hospital 4 2 1 3 3 6
Health centre/clinic 6 2 7 3 4
Dispensary 8 3 6 4 4
Pharmacy 3 13
Drug shop/ADDO 7 8
Total 18 7 17 14 10 31
Note: FBO/NGO = Faith-based and non-governmental organisation ownership.
Private= privately owned for-proﬁt.
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processes, and consumption of commodities in markets that cross na-
tional borders (Gereﬃ et al., 2005; Flecker et al., 2013). We examine
health sector procurement as a social and economic activity, including
complex front line labour processes and their implications for access to
treatment; wholesaling and related global trading and funding re-
lationships; and the impacts on local industrial development.
GVC analysis links governance of value chains to the type of item
traded and the complexity of transactions (Gereﬃ et al., 2005). While
the bulk of essential items purchased by the Kenyan and Tanzanian
health sectors are standard commodities, two major characteristics of
the production and distribution of essential medicines and supplies
diﬀer from standard commodity chains. The ﬁrst is the importance of
quality of medicines and medical supplies (Höllein et al., 2016).
Asymmetry of information, where quality cannot easily be judged by
users, implies central importance for regulation and quality assurance,
which in turn, we argue below, depends on eﬀective relational working
at all levels. The second characteristic is need: given current interna-
tional policy emphasis on moving towards universal access to appro-
priate treatment, essential medicines and supplies should be analysed
for policy purposes as inputs to this movement.
This article therefore explores procurement as a key governance
aspect of value chains linking industrial development, in East Africa
and abroad, to (potential) universal access to competent treatment. The
perspective of front line procurement staﬀ identiﬁes incentives and
constraints that shape local procurement rules and norms, drawing
methodologically on Abimola et al.'s (2014) investigation of local rule-
setting and multi-level governance. We then investigate institutional
changes in wholesale procurement for commercial and non-commercial
use, focussing on organisational inter-linkages, governance structures
and the leverage exercised by purchasing functions (Kaplinsky and
Morris, 2001). Finally, we investigate the impact of these procurement
trends and structures on locally based manufacturers' market access.
The discussion reﬂects on the implications for a more developmental
approach to procurement design.
4. Findings
4.1. Domestic supply chains: segmentation and interactions
Our quantitative data on wholesale sources of supplies by health
facility sector understate the complexity of sectoral interactions in
governance of access to supplies. Table 2 shows, for each facility sector,
the wholesale sector from which available tracer medicines and sup-
plies had been sourced. The “public” wholesale sector encompasses tax-
and donor-funded public procurement by the large public wholesaler
(KEMSA in Kenya, MSD in Tanzania), plus most of the vertical pro-
gramme supplies distributed by those wholesalers or through district
and city authorities. “Donations” were predominantly direct donations
of equipment to facilities. In Kenya, “FBO/NGO” wholesaling refers to
the Mission for Essential Drugs and Supplies (MEDS): a large Christian-
based non-proﬁt wholesaler established in 1986 to improve supplies to
non-proﬁt health facilities. Faith-based wholesalers in Tanzania exist
but were too small to register in these data. Table 2 shows that most
public facilities' available medicines and a smaller majority of supplies
came from the public wholesale sector, while the FBO facilities relied
mainly on private and NGO sources, and private facilities sourced from
private wholesalers.
The cross-overs between sectors identiﬁed in Table 2 include ver-
tical programme supplies from the public sector to the faith-based, NGO
and private facilities, and public sector “gap ﬁlling” from private sup-
pliers as described below. However Table 2 substantially under-
estimates inter-sectoral supply chain interactions, because public sector
treatment access also relies extensively on patients' private out-of-
pocket purchase of medicines and supplies from private shops.
4.2. Norms and relationships in front-line procurement
Health services' quality depends, as Abimola et al. (2014: ii23)
argue, on the strength and nature of working practices. Described as
“operational governance”, these are the norms and relationships that
shape day to day decisions, and are particularly inﬂuential where
formal governance of systems is weak or displays gaps. Medicines and
supplies are, for health facility staﬀ, essential inputs to treatment, and
the procurement routines and norms of behaviour of interviewees re-
ﬂected that needs-based perspective. Thus, when asked about pro-
curement activities and experience, those responsible in facilities did
not stop at the technical aspects of stock auditing and order form ﬁlling.
Facility-level procurement staﬀ in all sectors ordered and purchased
from wholesalers as well as from district authorities and local shops.
Their detailed accounts included systematic ways of addressing the
daily constraints they faced: procurement strategies and routines that
were notably relational and local in nature.
Health facilities were generally severely cash-constrained and
lacked market and institutional power: only a few private hospitals
serving insured patients reported some market leverage over choice of
supplies. Public facilities in both countries reported recurrent and often
severe supply shortages, while faith-based and private facilities strug-
gled with pricing and cash ﬂow constraints in a context of low ability to
pay. Adding to the lack of front line leverage over suppliers was the fact
that procurement was largely non-professionalised: in Tanzania, 59% of
facility interviewees actively engaged in procurement were doctors,
nurses or clinical oﬃcers, and in Kenya 41% (Table 3). Respondents
with formal procurement and supply management qualiﬁcations were
concentrated in hospitals. Over 20% of Tanzanian respondents were at
assistant or attendant level, but only 6% of Kenyan interviewees, while
Table 2
Tanzania and Kenya: wholesale source of tracer medicines and supplies in health facilities
(percentages by facility sector).
Health
facility
sector
Tanzania Kenya
Wholesale source sector Wholesale source sector
Public Donation Private Public FBO/
NGO
Donation Private
Medicines
Public 98 1 2 90 2 1 7
FBO/NGO 16 2 83 22 47 4 27
Private 6 94 1 99
Supplies
Public 86 11 4 64 1 15 20
FBO/NGO 20 19 61 20 37 9 35
Private 11 9 80 4 5 92
Note: totals may not add to 100 because of rounding.
Table 3
Qualiﬁcations of health facility procurement interviewees, by country and level of facility
(percentages by column).
Tanzania Kenya
Qualiﬁcation Hospital Lower level Hospital Lower level
Procurement/supply
management
14 2 22
Medical doctor/Assistant MO 10 9 4 4
Clinical oﬃcer/nurse 14 50 19 37
Pharmacist 19 5 19 22
Pharmacy/laboratory
technician/technologist
19 5 33 22
Nursing/pharmacy/laboratory
assistant/attendant
14 24 9
Public health/administration/
other
10 5 4 6
Total 100 100 100 100
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proportionately more Kenyan than Tanzanian interviewees had phar-
macy or laboratory training including stock management and ordering
(Table 3). In all, 53% of Kenyan and 73% of Tanzanian health facility
interviewees had no procurement training, short courses included.
Procurement work was therefore an element in a multi-tasking fa-
cility work process, squeezed into busy working days by clinicians, la-
boratory and dispensing staﬀ. The rules and practices of procurement
were embedded in the broader facility culture and subject to clinical
pressures. While procurement training addressed important skills of
stock control and timely, accurate form-ﬁlling, eﬀective procurement
was seen on the front line as dependent also on strong ‘horizontal’
working relationships within local areas, given the lack of power ex-
ercised in ‘vertical’ relations with wholesalers.
4.2.1. Public sector shortages and gap-ﬁlling
In the public sector, front-line staﬀ managed procurement in con-
texts of high uncertainty. Clinical interviewees stated that public
wholesalers' medicines were generally of good quality, but expressed a
number of complaints about the quality of equipment and supplies such
as gloves. Facility staﬀ lacked inﬂuence over the public wholesalers'
response to orders, and experience of recurrent stock outs and delayed
deliveries was almost universal. The following quotations are re-
presentative:
There was no medicine at this centre the whole of January.
(Tanzania, public dispensary)
At times we can stay for almost even six months without getting
these [speciﬁed] drugs. (Kenya, public dispensary)
Sometimes up to 45% of the order is reported missing. (Tanzania,
public district hospital)
Frontline procurement routines therefore allocated part of limited
staﬀ time to gap-ﬁlling, a rational response to patients' needs and
supply uncertainty. Gap-ﬁlling strategies all involved relationship-
building, including working with the district authorities. Some vertical
programme supplies were delivered to the District Medical Oﬃcer
(DMO) in Tanzania, and could be chased through the DMO's oﬃce. In
some Tanzanian districts, facilities visited had suﬃcient vertical pro-
gramme supplies, while in another district HIV tests had been missing
for a month. In Kenya, public wholesaler and vertical programme
supplies could come to dispensaries through the district hospital. In
each case, communication and logistics were complicated, requiring
local working relationships.
A widely reported gap-ﬁlling strategy in Kenya (but not in
Tanzania) was resort to borrowing (included within the public sector
category on Table 2). For this, relationships were key:
We normally share with other facilities. (Kenya, public health
centre)
We are forced to go to the other facilities … begging for drugs. Or
we barter, if the other facility requires paracetamol, we may trade
paracetamol for gloves or a similar arrangement. (Kenya public
health centre)
There was investment in mutual support:
Interviewer: Do you borrow to return or they give you and maybe
next time you replace?
No, no, when you borrow they just give you. But when you, later on
you might have a problem, you will assist them. Just creating a good
relationship. So when I have a problem, you'll help me. (Kenya
public health centre)
4.2.2. Funding procurement at the front line
Those responsible for front line public procurement constantly
chased additional funds, and their skills in accessing and using these
funds strongly inﬂuenced service quality. In Kenya the Health Sector
Services Fund (HSSF), and in Tanzania the donor-ﬁnanced Basket Fund
held at district level, were used by facilities to ﬁll emergency supply
gaps. The HSSF disbursed funds directly to health centres and dis-
pensaries (Opwora et al., 2011). Interviewees had used these funds for
cleaning items, casual labour for security, essential missing drugs, and
transport for urgent referrals among other items. The HSSF allowed
facilities to treat patients who were unable to pay for missing items:
We tell them [patients] to buy [but] some of them cannot aﬀord.
That is now where we try to squeeze out the HSSF fund. (Kenya
public health centre)
In Tanzania, the basket funds were used to buy essential items from
suppliers selected by the district authorities. A laboratory in-charge
explained:
… most laboratory supplies are always out of stock at [the public
wholesaler] … the procedure … starts by the laboratory technician
preparing a list and taking it to the DMO to sign as well as the
District Executive Director.… it is then taken to the supplies oﬃce,
who get quotations from the vendors, and the one with the cheapest
prices … is the one who wins the tender …. There is a risk of getting
low quality from the vendors because of the business-oriented,
proﬁt-making mentality. (Tanzania, public hospital)
This perception that buying medicines and supplies privately risked
lower quality than public supplies, is supported by recent literature
reviews (Höllein et al., 2016; Wafula et al., 2017: 61). Private market
quality concerns continue despite the regulatory eﬀorts of the Tanza-
nian Food and Drug Authority and the Kenyan Pharmacy and Poisons
Board. Furthermore, some private wholesalers in Kenya were reported
to refuse orders from public hospitals, fearing long payment delays.
Some public health facilities retained charges at facility level. However
many rural health centres and dispensaries in each country were not
permitted to do so or did not charge, leaving staﬀ with no petty cash for
private purchases or transport; some staﬀ reported using their own
money in crises.
4.2.3. Patients buying medicines and supplies
In both countries therefore, public sector patients were frequently
sent to private shops:
For a long time, we didn't have gloves … So we were buying for
emergencies. …. Even right now, a woman coming to the maternity
to deliver brings her own gloves … the stocks that are delivered [by
the public wholesaler] are spared for emergencies or for lab use.
(Kenya public health centre)
When medicines come late to our dispensary … patients go without
services …. they are told to go and buy medicines from private
shops. They complain about the prices there because most of our
customers are poor. (Tanzania public dispensary).
There are no systematic data in either country on the extent of
public sector facilities' reliance on patients' private purchases to deliver
current levels of service.
4.2.4. FBO and private sector procurement
The faith-based and private facilities and private shops were a key
element of access to treatment. In Kenya, FBO facilities were supplied
partly by MEDS and by some vertical programmes via the public sector;
they also relied on private wholesalers (Table 2). FBO facility inter-
viewees in Kenya were notably positive about MEDS' responsiveness to
their procurement demands, saying that MEDS oﬀered good quality,
short delivery times, and were responsive to complaints and to requests
for speciﬁc items. The availability data from our sample facilities bears
this out: among dispensaries and health centres, faith-based facilities
generally had higher availability of both medicines and supplies than
M. Mackintosh et al. Social Science & Medicine 200 (2018) 182–189
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the public facilities, and their staﬀ expressed more sense of control.
Private sector interviewees in shops and small facilities felt much
less sense of control of quality and price when ordering from whole-
salers. Private sector retail and facility buyers were generally very
price-focused, and also tied into wholesalers oﬀering credit:
Eﬃciency of supply, the credit period and also the competitiveness
of their prices: these are the three main things. (Kenya, private
clinic)
The main reasons why I chose those wholesale pharmacies are the
prices of the drugs, quality and the convenience each of them oﬀers.
(Tanzania private dispensary).
Yes, there are new suppliers in the market, but the only thing is that
you have to belong to a distributor because of the terms they oﬀer to
you. (Kenya drug shop)
The phrase ‘belonging’ to a distributor signals the relative power-
lessness of the small retailers, and the diﬃculty of switching supplier. In
each district, private sector interviewees relied on a small number of
dominant wholesalers. Supply mistakes, short expiry dates and sub-
stitutions were listed as recurrent problems in private sector procure-
ment interviews. Drug shop owners consistently struggled with ﬂuctu-
ating prices, cash ﬂow problems, and an acknowledged lack of control
over quality even from established wholesalers.
It is a free market so everyone has the right to set and change the
prices … sometimes it forces us to increase the sale price to custo-
mers, who in many cases don't have money. … Sometimes I am
forced to sell at a loss in order to keep my customers. (Tanzania,
ADDO)
The core purchasing constraint for many private sector interviewees
was the poverty of their customers, who were constantly seeking the
lowest prices, increasing the risk of purchasing substandard medicines.
4.3. Public, non-proﬁt and private wholesaling: market structure and
incentives
This lack of frontline power implies that the wholesale level of the
value chain exercised substantial leverage in the governance of the
system. Wholesaling, encompassing government, donor, faith-based
and private commercial bulk purchasing and distribution, powerfully
shapes market structure, and therefore retail and health facility-level
health care and medicines access. It also transmits incentives that in-
ﬂuence manufacturing business behaviour (Chataway et al., 2016;
Srinivas, 2012; Pazirandeh and Norrman, 2014).
In Tanzania and Kenya in recent years, wholesalers including large
public and non-proﬁt procurement bodies have been one force among
others for market liberalisation and globalisation of health sector sup-
plies. In both countries, private wholesaling of medicines creates a large
part of the total domestic market, supplying private facilities and re-
tailers and also non-governmental and public facilities (Table 2). Pri-
vate wholesaler/importers also sell medicines and supplies to public
and faith-based wholesalers. In Tanzania, private retail purchase alone
was estimated by interviewees to represent around half of the total
medicines market (vertical programmes included), while in Kenya one
oﬃcial estimate (MoMS & MPHS, 2010) put the private share of total
pharmaceutical expenditure at 80%. In both countries, the local tax-
funded share of public medicines expenditure is low: in Tanzania, 63%
of the public wholesaler's turnover was represented by vertical pro-
grammes in 2011/12, a ratio ﬂuctuating sharply year on year with the
size and timing of donor expenditure; part of the Tanzanian Treasury
contribution was also donor-funded (MSD, 2013; MoHSW, 2008: 4–5;
MSD oﬃce records). In Kenya, the bulk of public expenditure on
medicines was estimated to be donor-ﬁnanced (MM&MPHS, 2010).
It follows that donors' procurement practices, and private whole-
saling market structure and behaviour, between them dominated
domestic market-shaping in essential medicines and supplies. Public
wholesalers used large international tenders to procure medicines and
supplies. Large donors generally undertook international tendering di-
rectly, reducing the public wholesalers to logistics suppliers. This ap-
proach gave donors control of quality and payment, reducing their
organisational risk, but also undermined domestic industrial linkages.
Data in Table 4, combined with the interviews, conﬁrm that donors'
procurement practices have shifted the balance of sourcing of medi-
cines from local producers towards overseas (particularly Indian) sup-
pliers of essential medicines. In Kenya, reliance on Indian imports for
the chronic disease and other essential tracer medicines was low re-
lative to local suppliers, and in Tanzania 37% of other essential items
were regionally sourced (Table 4). However local manufacturers' shares
of the tracer medicines for HIV/AIDS (ARTs) and of the new ﬁrst-line
anti-malarial treatments (ACTs) were very low, as vertical programme
funders imported from India and high income country (HIC) manu-
facturers (Table 4). While local ﬁrms had supplied the bulk of the
previous ﬁrst line anti-malarial treatment (Sulfadoxine and Pyr-
imethamine, SP) (Mujinja et al., 2014), the switch to the new more
expensive ACTs as ﬁrst line treatment had raised barriers to market
entry by local ﬁrms. Subsequent to this data collection, the sole Tan-
zanian supplier of anti-retrovirals was closed.
In Kenya over half of publicly-sourced tracer medicines had been
bought locally, and in Tanzania over 20%, despite these constraints and
despite the use of international tendering as the public wholesalers'
main procurement method (Table 5). Private wholesalers had bought
proportionately less locally in each country. In Kenya, private whole-
sale buying from HICs (Table 5) reﬂected the market leverage of the
higher income segment of Kenya's private sector. Strikingly, faith-based
wholesalers interviewed, including MEDS in Kenya (Table 5) and Ac-
tion Medeor in Tanzania, were making major eﬀorts to purchase lo-
cally, as was PEPFAR in Tanzania when sourcing medicines for op-
portunistic infections. These organisations were actively adapting their
Table 4
Country of origin of all essential tracer medicines, by category of medicine and country of
use (percentages by medicine category) 2012.
Country of
use
Tanzania Kenya
Country of
origin
ACTs ARTs Chronic
disease
Other ACTs ARTs Chronic
disease
Other
Tanzania 10 19
Kenya 12 18 1 2 59 44
India 37 90 41 46 44 90 12 27
China 8 8 4 2 6
HICs 55 47 7 51 5 20 17
Other 2 2 7 6
Total 100 100 100 100 100 100 100 100
Note: ACT: artemisinin combination therapy; ART: antiretroviral therapy.
Table 5
Tanzania and Kenya: Country of origin of tracer medicines, by wholesale sector (% by
sector).
Country of
origin
Tanzania Kenya
Wholesale source sector Wholesale source sector
Public Donation Private Public FBO/
NGO
Donation Private
Tanzania 22 11
Kenya 10 25 20 54 76 50 32
India 49 25 47 30 8 40 31
China 6 6 8 1 4
HICs 12 50 12 8 10 10 25
Other 4 5 8
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procurement processes to working with local suppliers. Interviewees
attributed MEDS′ relatively high reliance on local procurement (at 75%,
see Table 5 Col. 5) to its mix of local tenders of accessible size and
active working relations with local manufacturers.
In both countries, interviewees including regulatory oﬃcials, public
and NGO wholesalers and clinicians, identiﬁed particular local manu-
facturers as producing reliable quality medicines, and also reported
problems, investigations and complaints about particular ﬁrms or pro-
ducts. Facility level and other interviewees argued that more local
public procurement could improve ﬂexibility and quality of local sup-
plies, by allowing enhanced regulatory oversight:
… the health system will be in a position to monitor right from the
primary stage of production, and quality of drugs would be assured
right at the factory level. (Tanzania, public health centre)
In both countries, the business model of private wholesaling and
distribution was strongly inﬂuenced by proﬁts from importing. Private
wholesaling was dominated by wholesalers/importers acting as re-
presentatives of Indian and multinational (MNC) exporters to East
Africa. In Kenya, some distributors acted mainly as marketing and
distribution agents for branded imports from MNCs such as Novartis,
Sanoﬁ and Astra Zeneca. Others had built up businesses as distribution
agents both for local manufacturers and for large Indian exporters such
as Cipla and Aurobindo (see also WHO, 2011). One distributor inter-
viewed represented two local manufacturers in tendering to KEMSA,
and this formed a substantial element of his local purchases; otherwise
he stated that he preferred importing, since imports were lower priced,
by implication allowing higher resale margins.
Distributors in Tanzania also acted as intermediaries between local
manufacturers and the public wholesaler. Tanzanian wholesaler/im-
porters bundled local and imported items to supply MSD tenders, and
one manufacturer of other health sector supplies was considering
moving into this business. There were a number of reasons why man-
ufacturers in Tanzania preferred indirect supply to the public sector.
Public tenders carried considerable risk: smaller manufacturers in
particular reported increasing delays in payment after delivery and
changes to contracted volumes during production. There was therefore
an incentive to shift this risk to an intermediary, despite reduced
margins. From the public wholesaler side, the attraction of bundling by
wholesalers included fewer contracted suppliers to deal with. Given the
wholesaling structure, this “bundling” would tend to incentivise a shift
over time to increasing reliance on imports.
4.4. Procurement patterns and local manufacturers' market access
These trends at wholesale level had had the eﬀect of weakening
domestic linkages between health sector procurement and local in-
dustry. Tanzania and Kenya each have active domestic pharmaceutical
and health supplies industries, largely owned by East African capital
(Banda et al., 2016; UNIDO, 2010). Kenya, with around 40 pharma-
ceutical ﬁrms and substantial upstream suppliers, is the regional hub.
Tanzania's smaller industry supplies mainly its domestic market. Both
countries' pharmaceutical sectors operated in a liberalised and globa-
lised market environment, with zero regional import duties on ﬁnished
pharmaceutical imports, and almost complete reliance on imports of
active pharmaceutical ingredients, excipients and machinery.
In 2009, these pharmaceutical industries were producing around a
third of domestic medicines' consumption (Table 6). However in Tan-
zania, local producers' market share of an expanding market had since
dropped sharply, to 15%, while exports had largely collapsed; mean-
while Kenyan producers had sustained their market share of a more
slowly growing market. Both countries had received rising volumes of
donor-funded medicines, particularly Tanzania. Data are unreliable
(UNIDO, 2010) but domestic market size, measured in Table 6 as local
production plus net imports, includes donor-funded medicines to the
extent that they were included in countries' import data.
Manufacturers interviewed stated that WHO pre-qualiﬁcation, re-
quired to tender for donor-funded contracts, was expensive in relation
to ﬁrms' revenues, and unlikely to generate business because of diﬃ-
culties in meeting the required scale and Asian manufacturers' tender
prices. The impact on market access was identiﬁable in both countries,
despite Kenya's stronger local industry (Table 4). In Tanzania, manu-
facturers stated that the shift to ACTs as ﬁrst-line anti-malarial medi-
cation, without access to donor-subsidised tenders, had reduced their
cash ﬂow, with one manufacturer reporting a loss of one third of
turnover from the switch. Loss of local suppliers potentially reduces
access by disadvantaged populations, since local producers in Tanzania
have been shown to distribute more eﬀectively than importers in rural
areas (Mujinja et al., 2014).
In Tanzania, the decline in market share was thus partly generated
by the terms of donor-funded procurement. A further blow was the loss
of industrial protection when import tariﬀs on medicines were removed
across the East African Community in 2009, increasing price competi-
tion from Asian exporters who may beneﬁt from domestic export sup-
port. The WHO, alongside large donors and NGOs, has argued for zero
import protection on medicines, characterising tariﬀs as a tax on illness
(Olcay and Laing 2008). Tanzanian interviewees conﬁrmed that this
view inﬂuenced trade policy. In both countries, manufacturers stated
that they now faced taxes or duties on some imported inputs, while
competing with duty-free imported formulations. While the public
wholesalers continue to provide up to 15% price premia for tenders
from local manufacturers, the cumulative impact of the changes has
been to increase barriers to market entry for local producers, with
particularly negative eﬀects in the less robust Tanzanian industrial
structure.
Kenyan manufacturers' market share may have been in part sus-
tained by the country's lower reliance on donor medicines funding,
alongside greater industrial capabilities of local ﬁrms. Kenyan manu-
facturers were supplying a broader range of essential medicines, in-
cluding those for chronic disease (diabetes, hypertension and mental
illness), and more technologically demanding items such as injectables
and IV ﬂuids. Tanzanian ﬁrms' range was narrower, mainly tablets,
capsules and some syrups – and was narrowing further.
Both countries also displayed high reliance on imports of medical
equipment and laboratory supplies (Table 7). China was emerging as a
supplier of medical equipment and supplies such as microscope slides
and glucometer strips, and Korea (among HICs) of diagnostics. Tan-
zania and Kenya were supplying domestically a majority of basics such
as brooms, bedsheets, disinfectant, bed nets and alcohol/spirit for
wound cleaning (Table 7). Kenyan manufacturers also produced ban-
dages, syringes and needles and some types of gloves, and exported
some of these items to Tanzania (Table 7).
Table 6
Kenya and Tanzania: pharmaceutical markets 2009 and 2013 (millions of current US
dollars) and market share of local manufacturers (%).
Country and
year
(1) Imports
(USD m)
(2) Exports
(USD m)
(3) Local
production (USD
m)
Local market
share (%)a
Kenya
2009 298.6 67.3 99.9 30
2013 466.4 82.1 193.1 33
Tanzania
2009 99.4 7.9 49.2 35
2013 286.1 1.7 48.7 15
Sources: Kenya: Imports, exports and local production: KNBS (2014, 2015). Mid-year
exchange rates from Central Bank of Kenya https://www.centralbank.go.ke/ consulted
17.2.16
Sources: Tanzania: Imports and exports: Comtrade data base http://comtrade.un.org/
data/ downloaded 5.8.14; local production URT (2012, 2013). Mid-year exchange rates
from Bank of Tanzania https://www.bot-tz.org/ consulted 12.2.16.
a Share calculated as (3)/((1) + (3)–(2)).
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Equipment and supplies are diverse, and relied on erratic and cash-
constrained locally-funded procurement. Private pharmaceutical
wholesalers dealt in medical supplies such as clinical gloves and la-
boratory items, and there were some specialist equipment wholesalers.
Medical supplies, like medicines, were imported tariﬀ-free, while pro-
ducers of e.g. hospital furniture complained of tariﬀs and taxes on their
imported inputs. Local producers of medical and laboratory supplies
and equipment thus faced similar competitive disadvantages to phar-
maceuticals suppliers. Overall, local manufacturers of medicines and
supplies for the health sector had lost out in access to rapidly expanding
market demand segments, notably donor-funded medicines, while fa-
cing increasingly risky and uneven public procurement patterns
alongside sharpening import competition in core domestic markets.
5. Discussion: a developmental perspective on procurement
Procurement processes, we have shown, act as a governance struc-
ture at multiple levels across the health sector, and connect need to
industrial development. Routines and constraints in front line pro-
curement processes embedded the workforce in ‘horizontal’ working
relationships that sought to improve access to treatment. In the public
sector, how staﬀ stitched together stock control, ordering, chasing the
public wholesaler and district authorities, borrowing, and purchasing
using a variety of funding sources, inﬂuenced treatment access. While
the strengths of public and donor procurement, according to facility
interviewees, were low prices and quality assurance, weaknesses were
not all attributable to local ordering and stock management failures.
Other causes identiﬁed included top-down working relationships gen-
erating relative powerlessness of frontline staﬀ, erratic and uneven ﬁ-
nancing, logistical problems, long geographical supply chains, and in-
ﬂexible tendering systems.
In the faith-based sector, facility staﬀ undertaking procurement
worked with faith-based wholesalers where available, and relied, like
larger private sector facilities, on working relationships with private
wholesalers they judged reputable through experience, but over whose
quality they lacked control. Patients in small private dispensaries and
drug shops, generally seeking the cheapest medicines, were the most
vulnerable to wholesale suppliers of medicines of doubtful quality.
Given the continuing persistence of access gaps and low incomes, a
broader perspective on procurement policy can embed it more securely
in health system strengthening, complementing a focus on strength-
ening top-down logistics. This shift in perspective should combine re-
cognition of the strengths within persistently uncertain funding con-
texts of multi-level governance of procurement rooted in eﬀective
relational working with an appreciation of the broader developmental
opportunities, as well as the problems, generated by power relations
within value chains.
In this framework, procurement emerges as an important arena for
both health and industrial policy. The GVC framework emphasises the
role of lead buyers in value chain governance, and historical research
identiﬁes how health care demand patterns structure supply industries
(Srinivas, 2012; Chataway et al., 2016). Health sector procurement
practices constitute “implicit” industrial policy, shaping pharmaceutical
and vaccine manufacturing in high- and middle-income countries
(Srinivas, 2012; Massard da Fonseca, 2017; Shadlen and Massard da
Fonseca, 2013; Pazirandeh and Norrman, 2014). Pharmaceutical
manufacturers have historically relied on domestic markets for their
early development, and the Africa-based pharmaceutical industry is no
exception (Banda et al., 2016).
Procurement in East Africa thus opens up developmental opportu-
nities, as Wang’Ombe and Mwabu (1987) noted two decades ago.
Building more eﬀective multi-level governance can strengthen links
between serving population health needs and supporting local in-
dustrial development. The challenge for public, NGO and donor pro-
curement is to sustain quality control while greatly increasing respon-
siveness to frontline requirements.
Strikingly, the non-commercial wholesaler in this study with the
best such responsiveness, MEDS, was also the wholesaler with the
strongest local purchasing, with resultant industrial and employment
beneﬁts. MEDS′ working practices were strongly relational, both up-
and down-stream, involving accreditation of local ﬁrms, regular con-
sultation with local manufacturers, in-house quality control, and rapid
response to facility requests and complaints. MEDS' relative success in
associating local procurement, quality assurance and downstream re-
sponsiveness shows that relational working processes can build mutual
understanding as a basis for eﬀective negotiation and market devel-
opment.
Public and non-proﬁt wholesalers can thus shorten supply chains
while encouraging domestic market competition through relational
working with local suppliers. This shift implies substantial working
practice changes within public and donor procurement. Because of the
central importance of quality, procurement for health care cannot be
arms-length. It requires inspection, quality assurance and control,
alongside knowledge sharing and a level of trust. These in turn require
better communications between procurement bodies and local ﬁrms,
and between procurement bodies and frontline staﬀ. Other supportive
policy changes, such as modest levels of tariﬀ protection to support
emerging industrial strengths, also require improved relational working
between health and industrial policy makers to identify scope for mu-
tual beneﬁt. Potential gains include industrial and employment growth,
and a reduction of a reliance on low-priced Indian imports that is
widely feared to be unsustainable as reputable Indian exporters move to
higher margin opportunities (Chaudhuri et al., 2010).
6. Conclusion
Access to essential medicines and supplies in the public sector
health facilities on which the bulk of Tanzanian and Kenyan low in-
come populations rely remains problematic and erratic. Local pro-
curement staﬀ were disempowered, and local industrial suppliers had
been weakened or constrained within a globalising market context.
Responsiveness to needs remained poor, and reliance on private
Table 7
Country of origin of tracer medical equipment and health sector supplies, by type of item and country of use (percentages by type of item) 2012.
Source country Tanzania Kenya
Medical equipment Supplies Medical equipment Supplies
Medical Lab Other Medical Lab Other
Tanzania 31 3 63
Kenya 5 4 13 7 38 16 73
India 7 2 4 17 3 2 1
China 15 20 3 3 17 30 4
HICs 75 41 85 3 67 23 74 11
Other 3 1 1 6 8 4 16
Total 100 100 100 100 100 100 100 100
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medicines purchases high.
The cultural and institutional changes required to shift to a more
domestically oriented, needs-led procurement mix can be built on the
strengths of current multi-level governance of procurement, alongside
eﬀective use of the market-shaping power of wholesale procurement.
Procurement can be made to function more eﬀectively as an active
policy ﬁeld for: assessing and transmitting need; sustaining access in
low income contexts with high uncertainty; generating greater re-
sponsiveness to population needs; and strengthening competent local
industrial suppliers; thus shifting more of the beneﬁts of health-related
industrial value chains towards the domestic economy. Better local
procurement by public and non-proﬁt wholesalers can generate wider
access to treatment, can support investment by competent, regulated
local manufacturers, and improve local distribution.
Increasingly these challenges are being addressed in East Africa. In
Tanzania the Second Five Year Development Plan (United Republic of
Tanzania (URT), 2016) identiﬁed pharmaceuticals as a priority in-
dustrial sector, encouraging public procurement to link actively with
local manufacturers. Generating eﬀective two-way relational working
between front-line procurement staﬀ, wholesalers and industrialists can
close the policy circle, extracting beneﬁts for both health care and in-
dustrial development.
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